BackEmmaus Life Sciences Overview

Emmaus Life Sciences Profit Margin

Emmaus Life Sciences (EMMA) has a profit margin of -38.79%, below the Healthcare sector average of 17.63%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

21.19%
↑ 152.60% YoY

As of Jun 2026

Annual Profit Margin (TTM)

-38.79%
↓ 60.30% YoY

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Emmaus Life Sciences (EMMA) FAQ

Emmaus Life Sciences (EMMA) currently reports a profit margin of -38.79% as of June 2026. That compares with -24.2% in the prior-year period — down 60.3% year over year. That is below the Healthcare sector average of 17.63%. Use the charts on this page to explore Emmaus Life Sciences's profit margin history and peer comparisons.

Emmaus Life Sciences's profit margin decreased from -24.2% to -38.79% — a 60.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Emmaus Life Sciences's profit margin of -38.79% is lower than the Healthcare sector average of 17.63%. That is roughly 320.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Emmaus Life Sciences's current -38.79% should be judged against Healthcare norms (sector average: 17.63%) and against EMMA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -38.79%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 17.63%. From there, open related valuation or income-statement pages for Emmaus Life Sciences, and consider following EMMA for alerts when major investors trade the stock.